No results for ‘’
Adeshwar Meditex Ltd
NSE: BSE: 543309
₹16.80
(0.88%)
Tue, 08 Sept 2026, 03:45 pm
Market Cap (in Cr)24.46
PE Ratio19.17
Dividend0
Health Technology
Medical Specialties
24.5KAdeshwar Meditex Income Statement
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 585.22M | 528.45M | 559.52M | 657.32M | 646.23M | 823.08M | 797.46M | 836.67M |
| Gross profit | 83.74M | 65.57M | 101.33M | 92.21M | 78.21M | 108.86M | 81.38M | 73.09M |
| Operating expenses (excl. COGS) | -33.00M | -31.04M | -51.49M | -50.57M | -49.64M | -62.87M | -36.66M | -34.86M |
| Selling/general/admin expenses, total | -33.00M | -31.04M | -51.49M | -50.57M | -49.39M | -62.48M | -36.64M | -34.26M |
| Research & development | — | — | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -33.00M | -31.04M | -51.49M | -50.57M | -49.39M | -62.48M | -36.64M | -34.26M |
| Other operating expenses, total | 0 | 0 | 0 | 0 | -256.00K | -383.00K | -21.00K | -598.00K |
| Operating income | 50.74M | 34.52M | 49.84M | 41.64M | 28.56M | 45.99M | 44.72M | 38.22M |
| Non-operating income, total | -14.90M | -3.31M | -20.78M | -18.23M | -16.65M | -16.95M | -16.86M | -10.29M |
| Interest expense, net of interest capitalized | -16.65M | -22.29M | -25.19M | -21.87M | -20.26M | -20.50M | -19.23M | -13.34M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 1.75M | 3.31M | 4.41M | 5.08M | 3.61M | 3.55M | 2.37M | 3.05M |
| Non-operating interest income | 961.00K | 1.44M | 2.17M | 1.57M | 0 | 0 | 0 | 0 |
| Miscellaneous non-operating expense | 785.00K | 1.88M | 2.24M | 3.50M | 3.61M | 3.55M | 2.37M | 3.05M |
| Unusual income/expense | 0 | 15.67M | 0 | -1.44M | 0 | 0 | 0 | 0 |
| Pretax income | 35.84M | 31.21M | 29.06M | 23.40M | 11.91M | 29.04M | 27.85M | 27.93M |
| Taxes | -10.23M | -8.71M | -7.90M | -6.63M | -3.98M | -8.30M | -7.77M | -7.28M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 25.61M | 22.51M | 21.16M | 16.77M | 7.93M | 20.74M | 20.08M | 20.66M |
| Net income | 25.61M | 22.51M | 21.16M | 16.77M | 7.93M | 20.74M | 20.08M | 20.66M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 25.61M | 22.51M | 21.16M | 16.77M | 7.93M | 20.74M | 20.08M | 20.66M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - |
| EBITDA | 54.40M | 38.05M | 53.20M | 45.10M | 32.38M | 51.30M | 50.73M | 43.22M |
| EBIT | 50.74M | 34.52M | 49.84M | 41.64M | 28.56M | 45.99M | 44.72M | 38.22M |
| Total operating expenses | -534.48M | -493.92M | -509.68M | -615.69M | -617.67M | -777.09M | -752.74M | -798.44M |
| Prepaid expenses | 390.00K | 616.00K | 420.86K | 1.60M | 4.12M | 2.65M | 1.92M | 1.31M |
| Deferred income, current | 909.00K | 1.18M | 0 | — | — | 1.17M | 1.23M | 8.90M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | — | — | — | — |
| Deferred income, non-current | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |